<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00860184</url>
  </required_header>
  <id_info>
    <org_study_id>VPD2008A</org_study_id>
    <secondary_id>5R44HL070576-05</secondary_id>
    <nct_id>NCT00860184</nct_id>
  </id_info>
  <brief_title>SmartRisk Stroke Prediction by MRI of Carotid Disease</brief_title>
  <acronym>SmartRisk</acronym>
  <official_title>Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VPDiagnostics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>VPDiagnostics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atherosclerotic plaque at the carotid artery bifurcation is a major source of stroke. The
      purpose of this investigation is to determine the ability of the SmartRisk software module to
      predict stroke or stroke-related events due to carotid plaque within a high-risk population.
      The SmartRisk software module operates on magnetic resonance images (MRI) of the carotid
      artery wall.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Carotid artery disease (atherosclerosis) is a major cause of stroke that can be treated with
      carotid endarterectomy surgery (CEA) or stenting. Subjects with moderate, asymptomatic
      stenosis (50-79% narrowing) typically do not undergo intervention because the procedural
      risks outweigh the benefits. However, some of these individuals will have vulnerable plaque
      that places them at high risk of stroke, but current diagnostic techniques for vulnerable
      plaque are lacking. Recently, VPDiagnostics developed a new module - SmartRisk - that
      stratifies risk of stroke for stenotic (50-79% blockage) atherosclerotic plaque. The
      SmartRisk module uses MRI data to compute a risk assessment from a specific atherosclerotic
      plaque. A continuous risk value is generated and patients with risk values above a
      prespecified threshold are at elevated risk for cerebrovascular events arising from carotid
      artery disease. The purpose of this trial is to determine whether the SmartRisk module is
      effective at stratifying risk of a carotid-related cerebrovascular event in subjects with
      asymptomatic 50-79% carotid stenosis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <primary_completion_date type="Anticipated">August 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>stroke or other cerebrovascular symptom (e.g. TIA)</measure>
    <time_frame>18 month mean follow-up at 6 month intervals</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>any cardiovascular event (e.g. MI)</measure>
    <time_frame>18 month mean follow-up at 6 month intervals</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Atherosclerotic Disease, Carotid</condition>
  <arm_group>
    <arm_group_label>50-79% stenosis</arm_group_label>
    <description>Subjects with 50-79% stenosis of the carotid artery Absence of prior ischemic neurological symptoms Age 18 or older</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patient referred for ultrasound assessment of carotid artery disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  50-79% stenosis of the carotid artery

          -  age 18 or older

          -  no ischemic neurovascular symptoms within preceding 6 months

        Exclusion Criteria:

          -  contraindication to MRI (e.g. weight &gt; 130 kg, pregnancy)

          -  prior or planned carotid endarterectomy or stenting

          -  history of atrial fibrillation

          -  prior neck irradiation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William S Kerwin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VPDiagnostics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Carl T. Hayden Medical Research Foundation</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond Q Migrino, MD</last_name>
      <email>raymond.migrino@va.gov</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prediman K Shah, MD</last_name>
      <email>shahp@cshs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Saloner, PhD</last_name>
      <email>saloner@radiology.ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tatjana Rundek, MD</last_name>
      <phone>305-243-7847</phone>
      <email>trundek@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard A Bernstein, MD</last_name>
      <email>richard.bernstein4@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kent Yucel, MD</last_name>
      <email>kyucel@tuftsmedicalcenter.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Greenman, PhD</last_name>
      <email>rgreenma@caregroup.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kumar Rajamani, MD</last_name>
      <email>krajaman@med.wayne.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Michigan State University</name>
      <address>
        <city>East Lansing</city>
        <state>Michigan</state>
        <zip>48824</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin DeMarco, MD</last_name>
      <email>J.DeMarco@radiology.msu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gotham Cardiovascular Research PC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cezar S Stanilaoe, MD</last_name>
      <email>Cezar.Stanilaoe@nyumc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Riles, MD</last_name>
      <email>Thomas.Riles@nyumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joel Morrisett, PhD</last_name>
      <email>morriset@bcm.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Joel Morrisett, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Institute for Biomedical Research</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerald Treiman, MD</last_name>
      <email>GSTREIMAN@EARTHLINK.NET</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xueqiao Zhao, MD</last_name>
      <email>xueqiao@u.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Xueqiao Zhao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Virginia University</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bob L Hou, PhD</last_name>
      <phone>304-293-1877</phone>
      <email>bhou@hsc.wvu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.vpdiagnostics.com</url>
    <description>VPDiagnostics website</description>
  </link>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2009</study_first_submitted>
  <study_first_submitted_qc>March 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2009</study_first_posted>
  <last_update_submitted>April 13, 2011</last_update_submitted>
  <last_update_submitted_qc>April 13, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2011</last_update_posted>
  <responsible_party>
    <name_title>William Kerwin / Vice President of Research and Development</name_title>
    <organization>VPDiagnostics, Inc.</organization>
  </responsible_party>
  <keyword>carotid artery</keyword>
  <keyword>atherosclerosis</keyword>
  <keyword>stroke</keyword>
  <keyword>transient ischemic attack</keyword>
  <keyword>MRI</keyword>
  <keyword>software</keyword>
  <keyword>risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Artery Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

